Argent BioPharma Limited
RGTLF
$0.0599
$0.011423.51%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -14.92M | -13.26M | -11.50M | -11.38M | -11.34M |
| Total Depreciation and Amortization | 831.20K | 628.80K | 420.70K | 461.20K | 508.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 7.73M | 5.09M | 2.38M | 1.55M | 734.30K |
| Change in Net Operating Assets | -912.90K | -912.90K | -912.90K | 235.30K | 1.40M |
| Cash from Operations | -7.27M | -8.46M | -9.61M | -9.13M | -8.70M |
| Capital Expenditure | -82.60K | -87.40K | -92.10K | -36.10K | 20.10K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 8.80K | 17.80K |
| Cash from Investing | -82.60K | -87.40K | -92.10K | -27.30K | 37.90K |
| Total Debt Issued | -- | -- | -- | 794.60K | 1.59M |
| Total Debt Repaid | -253.20K | -245.90K | -238.60K | -220.50K | -202.40K |
| Issuance of Common Stock | 5.69M | 10.82M | 15.94M | 16.95M | 17.96M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -30.80K | -233.60K | -436.40K | -674.40K | -912.40K |
| Cash from Financing | 3.57M | 6.78M | 9.98M | 11.04M | 12.14M |
| Foreign Exchange rate Adjustments | -8.40K | -4.40K | -400.00 | -2.30K | -4.30K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.79M | -1.77M | 273.20K | 1.88M | 3.47M |